Chronic Obstructive Pulmonary Disease (COPD)
Conditions
Interventions
Mini Program Group:routine follow-up plus a digital COPD management system
Non-mini program group:Routine Follow-up
Sponsors
No2 Hospital Affiliated to Liaoning University Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: (1) Age over 18 years old; (2) Patients who meet the diagnostic criteria for stable COPD; (3) COPD severity classified as grades 1-3, i.e., after inhaling sufficient short-acting bronchodilators, FEV1 <80% of the normal predicted value and =30% of the normal predicted value; (4) Voluntarily participating and signing the "Informed Consent Form"; (5) Patients with stable residence, able to provide detailed contact information, and no short-term relocation intentions, willing to cooperate with follow-ups.
Exclusion criteria
Exclusion criteria: (1) Patients currently diagnosed with asthma; (2) Other concurrent active or clinically significant respiratory diseases that may significantly impact the study, such as bronchial asthma, asthma-COPD overlap syndrome, bronchiectasis, active pulmonary tuberculosis, etc.; (3) Patients currently experiencing an acute exacerbation of COPD; (4) Patients who have undergone lung resection surgery or received lung volume reduction surgery within the past 12 months prior to screening; (5) Clinically significant sleep apnea requiring the use of continuous positive airway pressure (CPAP) devices or non-invasive positive pressure ventilation (NIPPV) devices; (6) Significant cardiovascular abnormalities (including but not limited to ischemic heart disease, NYHA III/IV grade left ventricular failure, myocardial infarction, arrhythmias, etc.), psychiatric, hepatic, or hematologic disorders that may interfere with the assessment of efficacy and safety; (7) Hypertensive patients with resting seated blood pressure after antihypertensive therapy: systolic >160 mmHg or diastolic >100 mmHg; (8) History of drug or alcohol abuse within the past 12 months; (9) Pregnant or breastfeeding women, or women planning to become pregnant or breastfeed during the study period; (10) Patients with impaired consciousness, dementia, or various psychiatric disorders; (11) Cancer patients who have undergone resection, radiotherapy, or chemotherapy within the past 5 years; (12) Patients unable to comply with the study protocol; (13) Any other factors deemed by the investigator to pose potential risks or interfere with the participation of the subject.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Compliance; | — |
Secondary
| Measure | Time frame |
|---|---|
| COPD comprehensive assessment criteria;Quality of Life Assessment Indicators;Pulmonary Function;Inhalation Technique Assessment Scale;Patient Satisfaction; | — |
Countries
China
Contacts
Public ContactYinghai Cui
No2 Hospital Affiliated to Liaoning University Traditional Chinese Medicine
Outcome results
None listed